588 related articles for article (PubMed ID: 16226920)
21. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells.
Grzeschik SM; Ganta M; Prior TW; Heavlin WD; Wang CH
Ann Neurol; 2005 Aug; 58(2):194-202. PubMed ID: 16049920
[TBL] [Abstract][Full Text] [Related]
22. In vitro restoration of functional SMN protein in human trophoblast cells affected by spinal muscular atrophy by small fragment homologous replacement.
Sangiuolo F; Filareto A; Spitalieri P; Scaldaferri ML; Mango R; Bruscia E; Citro G; Brunetti E; De Felici M; Novelli G
Hum Gene Ther; 2005 Jul; 16(7):869-80. PubMed ID: 16000068
[TBL] [Abstract][Full Text] [Related]
23. Spinal muscular atrophy: from gene to therapy.
Wirth B; Brichta L; Hahnen E
Semin Pediatr Neurol; 2006 Jun; 13(2):121-31. PubMed ID: 17027862
[TBL] [Abstract][Full Text] [Related]
24. SMN transcript stability: could modulation of messenger RNA degradation provide a novel therapy for spinal muscular atrophy?
Heier CR; Gogliotti RG; DiDonato CJ
J Child Neurol; 2007 Aug; 22(8):1013-8. PubMed ID: 17761657
[TBL] [Abstract][Full Text] [Related]
25. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.
Kashima T; Rao N; David CJ; Manley JL
Hum Mol Genet; 2007 Dec; 16(24):3149-59. PubMed ID: 17884807
[TBL] [Abstract][Full Text] [Related]
26. Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts.
Skordis LA; Dunckley MG; Yue B; Eperon IC; Muntoni F
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4114-9. PubMed ID: 12642665
[TBL] [Abstract][Full Text] [Related]
27. Restoration of full-length SMN promoted by adenoviral vectors expressing RNA antisense oligonucleotides embedded in U7 snRNAs.
Geib T; Hertel KJ
PLoS One; 2009 Dec; 4(12):e8204. PubMed ID: 19997596
[TBL] [Abstract][Full Text] [Related]
28. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.
Cartegni L; Krainer AR
Nat Genet; 2002 Apr; 30(4):377-84. PubMed ID: 11925564
[TBL] [Abstract][Full Text] [Related]
29. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2.
Monani UR; Lorson CL; Parsons DW; Prior TW; Androphy EJ; Burghes AH; McPherson JD
Hum Mol Genet; 1999 Jul; 8(7):1177-83. PubMed ID: 10369862
[TBL] [Abstract][Full Text] [Related]
30. The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells.
Riessland M; Brichta L; Hahnen E; Wirth B
Hum Genet; 2006 Aug; 120(1):101-10. PubMed ID: 16724231
[TBL] [Abstract][Full Text] [Related]
31. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.
Lorson CL; Hahnen E; Androphy EJ; Wirth B
Proc Natl Acad Sci U S A; 1999 May; 96(11):6307-11. PubMed ID: 10339583
[TBL] [Abstract][Full Text] [Related]
32. hnRNP M facilitates exon 7 inclusion of SMN2 pre-mRNA in spinal muscular atrophy by targeting an enhancer on exon 7.
Cho S; Moon H; Loh TJ; Oh HK; Cho S; Choy HE; Song WK; Chun JS; Zheng X; Shen H
Biochim Biophys Acta; 2014; 1839(4):306-15. PubMed ID: 24533984
[TBL] [Abstract][Full Text] [Related]
33. A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy.
Vezain M; Saugier-Veber P; Melki J; Toutain A; Bieth E; Husson M; Pedespan JM; Viollet L; Pénisson-Besnier I; Fehrenbach S; Bou J; Frébourg T; Tosi M
Eur J Hum Genet; 2007 Oct; 15(10):1054-62. PubMed ID: 17609673
[TBL] [Abstract][Full Text] [Related]
34. The survival motor neuron (SMN) protein: effect of exon loss and mutation on protein localization.
Le TT; Coovert DD; Monani UR; Morris GE; Burghes AH
Neurogenetics; 2000 Sep; 3(1):7-16. PubMed ID: 11085591
[TBL] [Abstract][Full Text] [Related]
35. Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy.
Jarecki J; Chen X; Bernardino A; Coovert DD; Whitney M; Burghes A; Stack J; Pollok BA
Hum Mol Genet; 2005 Jul; 14(14):2003-18. PubMed ID: 15944201
[TBL] [Abstract][Full Text] [Related]
36. Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes.
Singh NN; Singh RN; Androphy EJ
Nucleic Acids Res; 2007; 35(2):371-89. PubMed ID: 17170000
[TBL] [Abstract][Full Text] [Related]
37. Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells.
Angelozzi C; Borgo F; Tiziano FD; Martella A; Neri G; Brahe C
J Med Genet; 2008 Jan; 45(1):29-31. PubMed ID: 17932121
[TBL] [Abstract][Full Text] [Related]
38. Putting some spine into alternative splicing.
Khoo B; Akker SA; Chew SL
Trends Biotechnol; 2003 Aug; 21(8):328-30. PubMed ID: 12902166
[TBL] [Abstract][Full Text] [Related]
39. Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1.
Helmken C; Hofmann Y; Schoenen F; Oprea G; Raschke H; Rudnik-Schöneborn S; Zerres K; Wirth B
Hum Genet; 2003 Dec; 114(1):11-21. PubMed ID: 14520560
[TBL] [Abstract][Full Text] [Related]
40. Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophy.
Shababi M; Glascock J; Lorson CL
Hum Gene Ther; 2011 Feb; 22(2):135-44. PubMed ID: 20804424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
